These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 31975470

  • 1. Outcome of non-vitamin K oral anticoagulants in the treatment of left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.
    Lin C, Quan J, Bao Y, Hua W, Ke M, Zhang N, Jin Q, Xie Y, Wei Y, Ling T, Pan W, Wu L, Xie Y.
    J Cardiovasc Electrophysiol; 2020 Mar; 31(3):658-663. PubMed ID: 31975470
    [Abstract] [Full Text] [Related]

  • 2. [Effect of non-vitamin K antagonist oral anticoagulants on left atrial or atrial appendage thrombi in patients with nonvalvular atrial fibrillation].
    Cui J, Du X, Wu JH, Jia CQ, Li X, Ning M, Lyu J, Yang Y, Liu XH, Dong JZ, Ma CS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Aug 24; 46(8):606-610. PubMed ID: 30139010
    [Abstract] [Full Text] [Related]

  • 3. Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, Morandi E, van Eickels M, Cohen A.
    Am Heart J; 2015 Apr 24; 169(4):464-71.e2. PubMed ID: 25819852
    [Abstract] [Full Text] [Related]

  • 4. Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF).
    Lip GY, Hammerstingl C, Marin F, Cappato R, Meng IL, Kirsch B, van Eickels M, Cohen A, X-TRA study and CLOT-AF registry investigators.
    Am Heart J; 2016 Aug 24; 178():126-34. PubMed ID: 27502860
    [Abstract] [Full Text] [Related]

  • 5. Transesophageal vs. intracardiac echocardiographic screening in patients undergoing atrial fibrillation ablation with uninterrupted rivaroxaban.
    Tsyganov A, Shapieva A, Sandrikov V, Fedulova S, Mironovich S, Dzeranova A, Lyan E.
    BMC Cardiovasc Disord; 2017 Jun 29; 17(1):171. PubMed ID: 28662693
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients.
    Ke HH, He Y, Lv XW, Zhang EH, Wei Z, Li JY.
    J Thromb Thrombolysis; 2019 Aug 29; 48(2):270-276. PubMed ID: 31165950
    [Abstract] [Full Text] [Related]

  • 9. Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation.
    Fleddermann A, Eckert R, Muskala P, Hayes C, Magalski A, Main ML.
    Am J Cardiol; 2019 Jan 01; 123(1):57-62. PubMed ID: 30376957
    [Abstract] [Full Text] [Related]

  • 10. Non-vitamin K oral anticoagulants versus warfarin for left atrial appendage thrombus resolution in nonvalvular atrial fibrillation or flutter.
    Hussain A, Katz WE, Genuardi MV, Bhonsale A, Jain SK, Kancharla K, Saba S, Shalaby AA, Voigt AH, Wang NC.
    Pacing Clin Electrophysiol; 2019 Sep 01; 42(9):1183-1190. PubMed ID: 31355470
    [Abstract] [Full Text] [Related]

  • 11. Left atrial thrombus and dense spontaneous echocardiographic contrast in patients on continuous direct oral anticoagulant therapy undergoing catheter ablation of atrial fibrillation: Comparison of dabigatran, rivaroxaban, and apixaban.
    Wu M, Gabriels J, Khan M, Shaban N, D'Amato S, Liu CF, Markowitz SM, Ip JE, Thomas G, Singh P, Lerman B, Patel A, Cheung JW.
    Heart Rhythm; 2018 Apr 01; 15(4):496-502. PubMed ID: 29605015
    [Abstract] [Full Text] [Related]

  • 12. Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.
    Coleman CI, Peacock WF, Bunz TJ, Alberts MJ.
    Stroke; 2017 Aug 01; 48(8):2142-2149. PubMed ID: 28655814
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.
    Yao X, Abraham NS, Sangaralingham LR, Bellolio MF, McBane RD, Shah ND, Noseworthy PA.
    J Am Heart Assoc; 2016 Jun 13; 5(6):. PubMed ID: 27412905
    [Abstract] [Full Text] [Related]

  • 15. Direct comparative effectiveness and safety between non-vitamin K antagonist oral anticoagulants for stroke prevention in nonvalvular atrial fibrillation: a systematic review and meta-analysis of observational studies.
    Li G, Lip GYH, Holbrook A, Chang Y, Larsen TB, Sun X, Tang J, Mbuagbaw L, Witt DM, Crowther M, Thabane L, Levine MAH.
    Eur J Epidemiol; 2019 Feb 13; 34(2):173-190. PubMed ID: 29948370
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Successful direct thrombin inhibitor treatment of a left atrial appendage thrombus developed under rivaroxaban therapy].
    Szegedi N, Gellér L, Tahin T, Merkely B, Széplaki G.
    Orv Hetil; 2016 Jan 24; 157(4):154-6. PubMed ID: 26772828
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.